Vanita R. Aroda

Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial

Richard E. Pratley, Vanita R. Aroda, Ildiko Lingvay et al. · The Lancet Diabetes & Endocrinology · 2018 · 764 citations

Medicine, Pharmacology, Pharmacotherapy +13

Vitamin D Supplementation and Prevention of Type 2 Diabetes

Anastassios G. Pittas, Bess Dawson‐Hughes, Patricia Sheehan et al. · New England Journal of Medicine · 2019 · 664 citations · Full text

Medicine, Nutrition, Nutritional Sciences +17

Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial

Andrew Ahmann, Matthew Capehorn, G. Charpentier et al. · Diabetes Care · 2017 · 578 citations

Medicine, Pharmacology, Pharmacotherapy +16

Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study

Vanita R. Aroda, Sharon L. Edelstein, Ronald Goldberg et al. · The Journal of Clinical Endocrinology & Metabolism · 2016 · 522 citations · Full text

Medicine, Nutrition, Clinical Nutrition +16

PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes

Vanita R. Aroda, Julio Rosenstock, Yasuo Terauchi et al. · Diabetes Care · 2019 · 468 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17